Skanska announces order cancellation in Massachusetts, USA, worth USD 112M, about SEK 1.2 billion

Skanska announces that Continuus Pharmaceuticals has cancelled the project to build a pharmaceutical manufacturing facility in Woburn, Massachusetts, USA. The order cancellation is worth USD 112M, about SEK 1.2 billion, which will be recorded in the US order bookings for the second quarter of 2023.

For further information please contact:

Chris Mckniff, Communications Director, Skanska USA Building, tel +1 (347) 409 2719

Andreas Joons, Press Officer, Skanska AB, tel +46 (0)10 449 04 94

Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at www.skanska.com.

Skanska Group uses knowledge & foresight to shape the way people live, work, and connect. Over 135 years in the making, we’re one of the world’s largest project development and construction companies, with 2022 revenue totaling SEK 162 billion. We operate across select markets in the Nordics, Europe and USA. Together with our customers and the collective expertise of our 28,000 teammates, we create innovative and sustainable solutions that support healthy living beyond our lifetime.